Comparing Costs of Ischemic, Hemorrhagic Stroke
Survivors of hemorrhagic stroke incur more direct costs in the first 10 years than survivors of ischemic stroke.
Survivors of hemorrhagic stroke incur more direct costs in the first 10 years than survivors of ischemic stroke.
ICH is more common in young, female patients with HIV than those uninfected.
Multimorbidities and polypharmacy are more likely among those with stroke, increasing their treatment burdens and risk of adverse events.
Researchers suggest five healthy habits to cut stroke risk in women in half.
Neurologists should put more focus on neurological examinations to measure the effects of stroke intervention on brain function.
β-blocker use only lowers the risk of cardiovascular events in patients with prior myocardial infarction and with no heart failure, study finds.
Researchers confirmed that damage to the right frontal subcortical network after stroke may cause spacial bias between “where” and “aiming.”
A new study shows NSAID use significantly increases the risk of venous thromboembolism, though the cause remains unclear.
Other adverse conditions in patients with chronic kidney disease can explain higher risk of hemorrhage after thrombolytic therapy treatment for ischemic stroke.
Patients currently taking or given statins are over four times more likely to survive a hemorrhagic stroke. The study from Kaiser Permanente also showed the enzyme-inhibiting drug’s effectiveness in treating ischemic stroke.